According to our latest research, the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market size reached USD 3.1 billion in 2024. The market is expected to expand at a robust CAGR of 10.7% during the forecast period, reaching a projected value of USD 7.6 billion by 2033. This significant growth is driven by the increasing prevalence of PNH, advancements in novel therapeutics, and rising awareness among healthcare professionals and patients. The market’s expansion is further fueled by the continuous introduction of innovative drug classes and supportive care strategies, as well as enhanced diagnostic capabilities that enable earlier and more effective intervention. https://growthmarketreports.com/report/paroxysmal-nocturnal-hemoglobinuria-treatment-market-global-industry-analysis